Cite
HARVARD Citation
Osumi, H. et al. (2022). Multicentre single-arm phase II trial evaluating the safety and effiCacy of Panitumumab and iRinOtecan in NeoRAS Wild-type mEtaStatic colorectal cancer patientS (C-PROWESS trial): study protocol. BMJ open. 12 (9), p. . [Online].